论文部分内容阅读
目的:对某三甲医院抗肿瘤药物用药的现状和趋势做出评价。方法:对该院2000～2004年使用抗肿瘤药物进行回顾性分析。结果:抗肿瘤药销售金额逐年上升;抗肿瘤辅助治疗药格拉司琼连续5年销售金额名列第一;5年中抗雌激素类抗肿瘤药他莫昔芬用药频度排名稳居榜首,其他类抗肿瘤药顺铂位居第二;国产药物销售金额始终最大;医保类药物在该院具有较高使用率。结论:该三甲医院抗肿瘤药物结构基本合理;坚持研发和使用国产药物,不断降低药品费用。
Objective: To evaluate the current situation and trend of anti-tumor drugs in a top three hospital. Methods: The hospital from 2000 to 2004 using anti-tumor drugs were retrospectively analyzed. Results: The sales amount of antitumor drugs increased year by year. Granisetron, an antitumor adjuvant drug, ranked first for sales for five years in a row. The frequency of tamoxifen antinociceptive antitumor drugs topped the list for 5 years, Other anti-tumor drugs Cisplatin ranked second; sales of domestic drugs has always been the largest amount; Medicare drugs in the hospital has a higher utilization rate. Conclusion: The structure of anti-tumor drugs in this top three hospital is basically reasonable. It insists on research and development and use of domestically produced drugs, and continuously reduces the cost of medicines.